Skip to content

K-Stock Briefing

https://kstockbriefing.com

  • About Us
  • Weekly News
  • IR Room
  • RESEARCH
  • Disclosures
    • Semiconductors
    • Bio & Healthcare
    • Defense
    • Shipbuilding
    • Automotive
  • Toggle search form

[Disclosure] Wonik IPS (240810) – Setting of Record Date or Period for Suspension of Entry of Change in Shareholders’ Register / 2026-07-24

Posted on July 24, 2026August 3, 2026 By K-STOCK Editor No Comments on [Disclosure] Wonik IPS (240810) – Setting of Record Date or Period for Suspension of Entry of Change in Shareholders’ Register / 2026-07-24

Fact Source: Financial Supervisory Service DART

💡 3-Second Summary

Wonik IPS has set August 10, 2026, as the record date to confirm entitled shareholders who can exercise voting rights at the upcoming extraordinary general meeting of shareholders.

📊 [Key Disclosure Contents & Summary Metrics]

  • Record Date: August 10, 2026
  • Suspension Period for Registry Change: Not Applicable
  • Reason for Setting: Determination of shareholders entitled to vote at the extraordinary general meeting of shareholders
  • Board Resolution Date: July 24, 2026
  • Other Investment Considerations:
    • Pursuant to Article 13 (Closure of Shareholders’ Register and Record Date) of the Articles of Incorporation.
    • In accordance with the Act on Electronic Registration of Stocks, Bonds, etc., no separate suspension period for registry changes is established.

📝 Editor’s Comment (Key Follow-up Checkpoint)

📌 Verification of Record Date for Voting Rights and Official Disclosures

This disclosure serves as a formal notice establishing a record date to identify shareholders entitled to attend and vote at the upcoming extraordinary general meeting. Understanding that shareholders holding shares as of August 10 are granted voting rights is essential for confirming eligibility to participate in the general meeting. Specific meeting agendas and outcomes can be verified through the related ‘Decision on Calling of General Shareholders’ Meeting’ disclosure and the subsequent ‘Results of General Shareholders’ Meeting’ disclosure.

📢 Disclaimer & Source Notice

Source: This content is structured and rewritten based on official data submitted to the Financial Supervisory Service’s Data Analysis, Retrieval and Transfer System (DART).

Investment Risk Warning: This content is provided for informational and language reference purposes only. Under no circumstances does it constitute financial advice or a recommendation to buy or sell any specific stock. All investment decisions and financial responsibilities rest solely with the investor.

Contact: For compliance inquiries or copyright requests, please contact ksb220805@gmail.com.

Search by
Company Name or Stock Ticker.
Disclosures, Semiconductors

Post navigation

Previous Post: [Disclosure] Wonik IPS (240810) – Decision on Calling of General Shareholders’ Meeting / 2026-07-24
Next Post: [Disclosure] Celltrion (068270) – CT-P13 SC (Zymfentra) Korea Phase 3 Clinical Trial Plan Application (Rheumatoid Arthritis Patients) / 2026-07-24

Related Posts

[Disclosure] PSK Holdings (031980) – Investor Relations (IR) Host / 2024-11-08 Semiconductors
[Disclosure] Hanwha Aerospace (012450) Sets Record Date (December 31, 2024) for 48th Annual General Meeting of Shareholders Disclosures
[Disclosure] LEENO Industrial (058470) – Modification Listing (Change in Par Value) (Stock Split) / 2025-04-24 Disclosures
[Disclosure] Daeduck Electronics (353200) – New Facility Investment / 2026-07-20 Disclosures
[Disclosure] Hanwha Aerospace (012450) Confirms Final Subscription Price at KRW 684,000 for KRW 2.9T Paid-in Capital Increase Disclosures
[Disclosure] Celltrion (068270) – Decision on Bonus Issue (Correction) / 2025-05-28 Bio & Healthcare

Leave a Reply Cancel reply

You must be logged in to post a comment.

  • [Disclosure] Hanwha Ocean (042660) – Clarification on Rumors or Reports (Unconfirmed) / 2026-08-07August 7, 2026
  • [Disclosure] ALTEOGEN (196170) – Exclusive License Agreement for Recombinant Human Hyaluronidase Product ALT-B4 / 2026-08-05August 5, 2026
  • [Disclosure] ALTEOGEN (196170) – Ex-Rights (Bonus Issue) / 2026-08-04August 4, 2026
  • [Disclosure] ALTEOGEN (196170) – Market Measures on Stock Futures and Options (Bonus Issue) / 2026-08-04August 4, 2026
  • [Disclosure] Celltrion (068270) – CT-P44 (Darzalex Biosimilar) Korea Phase 3 Clinical Trial Plan Amendment Application / 2026-08-03August 3, 2026

Copyright © 2026 K-Stock Briefing.

Powered by PressBook Grid Dark theme